Deciduous Therapeutics, Inc. — Form D
Deciduous Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-10. The offering totals $6.5M, of which $5.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-07-10
- Form: D
- Accession: 0001781131-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $5.8M
- Remaining: $654K
- Minimum investment: $10K
- Investors: 10
- Date of first sale: 2019-06-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-343931
Issuer
- Name: Deciduous Therapeutics, Inc.
- CIK: 0001781131
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 650-206-9082
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Anil Bhushan | Director | San Fransicso, CA |
| Robin Mansukhani | Director | San Fransicso, CA |
| DYLAN MORRIS | Director | Watertown, MA |
| Robin Mansukhani | Executive Officer | San Fransicso, CA |
More